NM_000059.4(BRCA2):c.8754+249G>A AND Breast-ovarian cancer, familial, susceptibility to, 2
- Germline classification:
- Benign (1 submission)
- Last evaluated:
- Jan 12, 2015
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000191786.1
Allele description [Variation Report for NM_000059.4(BRCA2):c.8754+249G>A]
NM_000059.4(BRCA2):c.8754+249G>A
Condition(s)
-
hypothetical protein GLYMA_15G122400v4 [Glycine max]
hypothetical protein GLYMA_15G122400v4 [Glycine max]gi|947062386|gb|KRH11647.1||gnl|WGS |GLYMA_15G1224001pProtein
-
lorglumide [Supplementary Concept]
lorglumide [Supplementary Concept]RN given refers to (+-)-isomer<br/>Date introduced: April 17, 1986<br/>MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024